170 related articles for article (PubMed ID: 38566990)
1. Myeloid-derived suppressor cell-derived osteoclasts with bone resorption capacity in the joints of arthritic SKG mice.
Fujikawa Y; Sendo S; Del Peral Fanjul A; Yamada H; Uto K; Yamamoto Y; Nagamoto T; Morinobu A; Saegusa J
Front Immunol; 2024; 15():1168323. PubMed ID: 38566990
[TBL] [Abstract][Full Text] [Related]
2. Myeloid-derived suppressor cells contribute to bone erosion in collagen-induced arthritis by differentiating to osteoclasts.
Zhang H; Huang Y; Wang S; Fu R; Guo C; Wang H; Zhao J; Gaskin F; Chen J; Yang N; Fu SM
J Autoimmun; 2015 Dec; 65():82-9. PubMed ID: 26318644
[TBL] [Abstract][Full Text] [Related]
3. CD11b+Gr-1
Sendo S; Saegusa J; Okano T; Takahashi S; Akashi K; Morinobu A
Arthritis Rheumatol; 2017 Dec; 69(12):2314-2327. PubMed ID: 28805019
[TBL] [Abstract][Full Text] [Related]
4. Effect of Advanced Oxidation Protein Products (AOPPs) and aging on the osteoclast differentiation of Myeloid-Derived Suppressor Cells (MDSCs) and its preliminary mechanism.
Zou L; Jiang W; Wang Z; Chen J; Zhu S
Biochem Biophys Res Commun; 2022 Dec; 636(Pt 2):87-96. PubMed ID: 36368159
[TBL] [Abstract][Full Text] [Related]
5. Microsomal prostaglandin E synthase-1 promotes lung metastasis via SDF-1/CXCR4-mediated recruitment of CD11b
Takahashi R; Amano H; Ito Y; Eshima K; Satoh T; Iwamura M; Nakamura M; Kitasato H; Uematsu S; Raouf J; Jakobsson PJ; Akira S; Majima M
Biomed Pharmacother; 2020 Jan; 121():109581. PubMed ID: 31715374
[TBL] [Abstract][Full Text] [Related]
6. miR-223 suppresses differentiation of tumor-induced CD11b⁺ Gr1⁺ myeloid-derived suppressor cells from bone marrow cells.
Liu Q; Zhang M; Jiang X; Zhang Z; Dai L; Min S; Wu X; He Q; Liu J; Zhang Y; Zhang Z; Yang R
Int J Cancer; 2011 Dec; 129(11):2662-73. PubMed ID: 21213211
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function.
Charles JF; Hsu LY; Niemi EC; Weiss A; Aliprantis AO; Nakamura MC
J Clin Invest; 2012 Dec; 122(12):4592-605. PubMed ID: 23114597
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of B220
Zhang Z; Huang X; Wang E; Huang Y; Yang R
Oncoimmunology; 2021 Apr; 10(1):1912472. PubMed ID: 33948392
[TBL] [Abstract][Full Text] [Related]
9. Age-related expansion and increased osteoclastogenic potential of myeloid-derived suppressor cells.
Li Z; Zhao Y; Chen Z; Katz J; Michalek SM; Li Y; Zhang P
Mol Immunol; 2021 Sep; 137():187-200. PubMed ID: 34274794
[TBL] [Abstract][Full Text] [Related]
10. Monocytic MDSCs skew Th17 cells toward a pro-osteoclastogenic phenotype and potentiate bone erosion in rheumatoid arthritis.
Chen S; Guo C; Wang R; Feng Z; Liu Z; Wu L; Zhao D; Zheng S; Chen F; Zhang D; Xu J; Zhu J; Chen X; Li Z; Wise CM; Li J; Wang XY
Rheumatology (Oxford); 2021 May; 60(5):2409-2420. PubMed ID: 33246326
[TBL] [Abstract][Full Text] [Related]
11. ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer.
Chen H; Yang K; Pang L; Fei J; Zhu Y; Zhou J
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822671
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer modulates the immunosuppressive function of CD11b
Udumula MP; Sakr S; Dar S; Alvero AB; Ali-Fehmi R; Abdulfatah E; Li J; Jiang J; Tang A; Buekers T; Morris R; Munkarah A; Giri S; Rattan R
Mol Metab; 2021 Nov; 53():101272. PubMed ID: 34144215
[TBL] [Abstract][Full Text] [Related]
13. Tofacitinib facilitates the expansion of myeloid-derived suppressor cells and ameliorates arthritis in SKG mice.
Nishimura K; Saegusa J; Matsuki F; Akashi K; Kageyama G; Morinobu A
Arthritis Rheumatol; 2015 Apr; 67(4):893-902. PubMed ID: 25545152
[TBL] [Abstract][Full Text] [Related]
14. Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow.
Poh TW; Bradley JM; Mukherjee P; Gendler SJ
Cancer Res; 2009 Apr; 69(8):3554-62. PubMed ID: 19351842
[TBL] [Abstract][Full Text] [Related]
15. Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells.
Zhuang J; Zhang J; Lwin ST; Edwards JR; Edwards CM; Mundy GR; Yang X
PLoS One; 2012; 7(11):e48871. PubMed ID: 23173040
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction.
Danilin S; Merkel AR; Johnson JR; Johnson RW; Edwards JR; Sterling JA
Oncoimmunology; 2012 Dec; 1(9):1484-1494. PubMed ID: 23264895
[TBL] [Abstract][Full Text] [Related]
17. Tofacitinib facilitates the expansion of myeloid-derived suppressor cells and ameliorates interstitial lung disease in SKG mice.
Sendo S; Saegusa J; Yamada H; Nishimura K; Morinobu A
Arthritis Res Ther; 2019 Aug; 21(1):184. PubMed ID: 31387650
[TBL] [Abstract][Full Text] [Related]
18. Graft-Versus-Host Disease Prevention by
Scheurer J; Kitt K; Huber HJ; Fundel-Clemens K; Pflanz S; Debatin KM; Strauss G
Front Immunol; 2021; 12():754316. PubMed ID: 34721430
[TBL] [Abstract][Full Text] [Related]
19. [Mesenchymal stem cells promote mouse breast tumor progression by inducing the suppressive function of myeloid-derived CD11b⁺ Gr1⁺ cells].
Hu X; Luo Y; Zhou Y; Zhao D; Wu W; Han Z; Feng X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):785-8. PubMed ID: 25108426
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-Derived Suppressor Cells Confer Infectious Tolerance to Dampen Virus-Induced Tissue Immunoinflammation.
Sarkar R; Mathew A; Sehrawat S
J Immunol; 2019 Sep; 203(5):1325-1337. PubMed ID: 31331972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
